590 Pre-conditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy

• Christianne Groeneveldt,
• Priscilla Kinderman,
• Jim Middelburg,
• Diana JM van den Wollenberg,
• Ruben L van den Oever,
• Dana AM Mustafa,
• Rob Hoeben,
• Thorbald van Hall,
• Nadine Van Montfoort

Affiliations

Christianne Groeneveldt

Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands

Priscilla Kinderman

Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands

Jim Middelburg

Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands

Diana JM van den Wollenberg

1Leiden University Medical Center, Leiden, Netherlands

Ruben L van den Oever

1Leiden University Medical Center, Leiden, Netherlands

Dana AM Mustafa

2University Medical Center Rotterdam, Rotterdam, Netherlands

Rob Hoeben

1Leiden University Medical Center, Leiden, Netherlands

Thorbald van Hall

1Leiden University Medical Center, Leiden, Netherlands

Nadine Van Montfoort

1Leiden University Medical Center, Leiden, Netherlands